InvestorsHub Logo

bagfull

01/23/09 7:32 PM

#62 RE: FTR #61

Potential revenues from Polyheme is Huge if approved. I am not concerned about that at all. I am concerned about the fact that FDA is still not ready to approve blood substitute products in the market due to safety concerns. Lets see